Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Series A brings in $12.6mm for Rheonix

Executive Summary

Rheonix Inc. (developing point-of-care tests for infectious diseases) has closed its Series A financing, raising $12.6mm from a group of regional and international firms led by the Cayuga Venture Fund and individual investors. The funds will support ongoing development of the company's CARD (Chemistry And Reagent Device) platform that incorporates high-throughput molecular diagnostics into a single system.
Deal Industry
  • Biotechnology
    • Nanotechnology, Chips, etc.
  • In Vitro Diagnostics
    • Biosensors
    • Chemistry, Immunoassay
    • Molecular Diagnostics & Genetic Testing
  • Medical Devices
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

UsernamePublicRestriction

Register